HAAS NATHAN

PrivateCIK: 1954273
Location

DENVER, CO

HAAS NATHAN enters VITRO BIOPHARMA, INC. with 1.88M shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderHAAS NATHANCIK 1954273
IssuerVITRO BIOPHARMA, INC.CIK 793171
Officer· Chief Financial Officer
Since Nov 2022
1.88M
Baseline shares
100% direct
1.88M
Direct ownership
1 position
2.54M
Derivative underlying
6 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned1.88M
Total
1.88M direct1.88M
Derivative Holdings6

Warrant (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

400K

Shares owned

N/A

Exercise price

1.00

Expiration

Exercise window

Warrant (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

400K

Shares owned

N/A

Exercise price

0.50

Expiration

Exercise window

Employee Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

1M

Shares owned

N/A

Exercise price

0.50

Expiration

Exercise window

Warrant (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

120K

Shares owned

N/A

Exercise price

0.50

Expiration

Exercise window

Employee Stock Option (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

500K

Shares owned

N/A

Exercise price

0.50

Expiration

Exercise window

Warrant (Right to Buy)

Direct
Underlying security
Common Stock

Underlying shares

120K

Shares owned

N/A

Exercise price

1.00

Expiration

Exercise window

Total

Underlying

2.54M

Owned

0.00

HAAS NATHAN — Initial Ownership Disclosure (Form 3) Filed Nov 14, 2022 | Finecho